Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
10/2003
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1007527B1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
10/29/2003CN1452489A Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
10/29/2003CN1452484A Anthelmintics for preventing parasitic infections inhumans and animals
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451383A Use of albendazole sulfoxide and oxfendazole for preventing and treating fish parasite disease
10/29/2003CN1125824C Antiparasitic marcfortines
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087322A2 Production of haematophagous organisms and parasites suitable for vaccine production
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003086469A1 Ethyl cellulose-containing veterinary sustained release injection
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086415A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199694 Thermally stable trimetrexates and processes for producing the same
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199476 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003CA2483820A1 Production of haematophagous organisms and parasites suitable for vaccine production
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2480814A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1353926A1 Mikanolide derivatives, their preparation and therapeutic uses
10/22/2003EP1353679A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353622A2 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450923A Method and compositions for administering taxanes orally to human patients
10/21/2003US6635462 Mutated form of arginine deiminase
10/21/2003CA2288003C Pharmaceutical compositions of tizoxanide and nitazoxanide
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085072A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003041660A3 Solubilized topoisomerase poisons
10/16/2003WO2003031393A3 Carbonyloxy-cyanomethyl compounds as antiparasitic agents
10/16/2003WO2002102307A3 Nucleoside vaccine adjuvants
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002024307A3 Reducing the content of particular cell types in a biological sample
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195196 Pyrrolobenzodiazepines
10/16/2003US20030195171 Method for inhibiting bone resorption with an alendronate and vitamin D formulation
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194414 Replikin peptides and antibodies therefore
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1351940A1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351930A2 Protease inhibitors
10/15/2003EP1351678A2 Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
10/15/2003EP1071409B1 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
10/15/2003EP0986564B1 6-SUBSTITUTED 1,2,4A,5A,8A,8A HEXAHYDRO- AND 1,2,3,4,4A,5A,8A,8B-OCTAHYDRO-6H-PYRROLO[3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ONE DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
10/15/2003CN1449024A Erase scheme for non-volatile memory
10/15/2003CN1448393A Novel dioxomorpholine for antiendoparasite
10/15/2003CN1448133A Daphnetin and arteannuin derivative compatible anti-malaria composition
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632822 Compounds and therapeutic methods
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082852A1 Novel substituted 1,2,4-trioxanes useful as antimalarial agents and a process for the preparation thereof
10/09/2003WO2003082836A1 New dioxomorpholines for combating endoparasites
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191082 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191057 Cardiovascular disorders; antiinflammatory agents
10/09/2003US20030190613 Polynucleotide encoding an activated human T-lymphocyte-derived protein related to ubiquitin conjugating enzyme
10/09/2003US20030190365 Mixing non-dihydrate azithromycin particles with granulating amount of granulating liquid and optionally excipients to form wet granules which comprise non-dihydrate azithromycin and the granulating liquid
10/09/2003US20030190330 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
10/09/2003CA2481232A1 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003CA2480128A1 Methods of using flt3-ligand in immunization protocols
10/08/2003EP1351252A1 Erase scheme for non-volatile memory
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 218